Acute treatment of migraine in emergency room: Open comparative study between dexametasone and haloperidol. Preliminary results;Tratamento agudo da crise de enxaqueca refratária na emergencia: Estudo comparativo entre dexametasona e haloperidol. Resultados preliminares

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 2 B, 2004, Pages 513-518

  Monzillo, Paulo H ^a,b   Nemoto, Patricia H ^a   Costa, Agnaldo R ^a   Sanvito, Wilson L ^a,b  

^a Disc Neurol S Casa de S Paulo SP   (Brazil)

^b Neurologia ^*  (Brazil)

Author keywords

Dexametasone; Emergency room; Haloperidol; Migraine; Side effects

Indexed keywords

DEXAMETHASONE; DIPYRONE; HALOPERIDOL;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; BRAZIL; CLINICAL ARTICLE; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HUMAN; MALE; MIGRAINE; PAIN ASSESSMENT; SIDE EFFECT; TREATMENT OUTCOME;

EID: 3142762614     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000300025     Document Type: Article

References (32)

1. Ward TN. Management of an acute primary headache. Clin Neurosci 1998;5:50-54.
2. Olenick JS, Taylor RB. Emergency evaluation and treatment of headache. Prime Care 1986;13:97-107.
3. Fragoso YD, Fonseca PL, Fortinguerra MB, Caminato L, Matte GDO, Oliveira CM. Management of primary headache in emergency services of Santos and surrounding towns. Rev Paul Med 1998;116:1650-1653.
4. Bigal ME, Bordini CA, Speciali JG. Headache treatment in an emergency unit of the city of Ribeirão Preto, Brazil. Arq Neuropsiquiatr 1999;57:813-819.
5. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double - blind, placebo controlled study. Headache 2002;42:862-871.
6. Silberstein SD. Practice parameter evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762.
7. Mascia A, Afra J, Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological and therapeutic data. Cephalalgia 1998;18:174-182.
8. Peroutka SJ. Dopamine and migraine. Neurology 1997;49:650-656.
9. Emilien G, Maloteaux JM, Geurts M, Hoogenberg K, Cragg S. Dopamine receptors: physiological understanding to therapeut intervention potential. Pharmacol Ther 1999;84:133-156.
10. Fanciullacci M, Alessandri M, Del Rosso A. Dopamine involvement in the migraine attack. Funct Neurol 2000;15(Suppl 3):171-181.
11. Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Official Journal of the Society for Acad Emerg Med 1995;2:597-602.
12. Tanen DA, Miller S, French T, Riffenburg RH. Intravenous sodium valproate vs prochlorperazine for the emergency department treatment of acute migraine headaches prospective, randomized, double-blind trial. Ann Emerg Med 2003;41:847-853.
13. Kelly AM, Ardagh M, Curry C, D'Antonio J, Zebic S. Intravenous chlorpromazine vs intramuscular sumatriptan for acute migraine. Accid Emerg Med 1997;14:209-211.
14. Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura: a prospective randomized double-blind trial. Arch Intern Med 1996;156:1725-1728.
15. Ginder S, Oatman B, Pollack M. A prospective study of i.v. magnesium and i.v. prochlorperazine the treatment of headaches. J Emerg Med 2000;18:311-315.
16. Costa AR, Monzillo PH, Sanvito WL. Uso de dorpromazina para tratamento de cefaléia no serviço de emergência. Arq Neuropsiquiatr 1998;56:565-568.
17. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1998;8(Suppl 7):1-96.
18. Welch KM A. Drug therapy of migraine. N Engl J Med 1993;329:1476-1483.
19. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-311.
20. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002;346:257-270.
21. Lane P. New prescriptions for migraine in the emergency department. Can Family Phsysician 1992;38:1451-1456.
22. Migraine report. Highlights of a Canadian Consensus conferencia, Toronto. The Medicine Group (Canada) Ltd; 1993:1-4.
23. Nix WA. What is certain in pain therapy? The analgesic potency of neuroleptics in the treatment of chronic pain: a metaanalysis. Schmerz 1998;12:30-38.
24. Patty RB, Proper G, Reddy S. The neuroleptics as adjuvant analgesics. J Pain Symptom Manag. 1994;9:446-453.
25. Clinton JE, Sterner S, Stelmachers Z, Ruiz E. Haloperidol for sedation of disruptive emergency patients. Ann Emerg Med 1987;16:319-332.
26. Goodman and Gillman' s. The pharmacological basis of therapeutics, 8 th ed. Elmsford, New York: Pergamon Press, 1990:386-404.
27. Fisher H. A new approach to emergency therapy of migraine headache with intravenous Haloperidol: a case series. J. Emerg Med 1995;13:119-122.
28. Settle EC. Haloperidol: a quarter century of experience. J Clin Psychiatry 1983;44:440-448.
29. Gallagher RM. Emergency treatment of intractable migraine. Headache 1986;26:74-75.
30. Levine BD, Yoshimura T, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1987;321;1707-1719.
31. Klapper JA, Stanton JS. The emergency treatment of acute migraine headache: a comparison of intravenous dihydroergotamine, dexamethasone and placebo. Cephalalgia 1991;11(Suppl 11):159-160.
32. Saper JR, Silberstein SD, Gordon CD, Hamel RL. Handbook of headache management. Baltimore: Williams&Wilkins, 1993.